ERBB2 and neoplasm: The risk score of ALPS model was significantly correlated with Stage, ER status, PR status and HER2 status (Table 1): risk score of stage III‐IV is significantly higher than stage I‐II’s (P < 0.001), and risk score of T3‐4 is significantly higher thanT‐2’s (P = 0.01), etc Figure 4 showed that the risk score of ALPS model differed according to clinicopathological features and tumour.